Mario Löhr

Weitere Beteiligungen

• 27.10.2022

  14:00 – 14:10 7 Min. 3 Min.

  • Abstractvortrag

  Pharmaceutical Screening in a ex vivo tumor slice model for vestibular schwannoma
• 27.10.2022

  14:20 – 14:30 7 Min. 3 Min.

  • Abstractvortrag

  Tumormicroenvironment in Vestibular schwannoma with and without NF2
• 27.10.2022

  16:35 – 16:45 7 Min. 3 Min.

  • Abstractvortrag

  Voxel-based lesion symptom mapping of deficits of the lexical word fluency in patients with glioblastoma
• 28.10.2022

  10:15 – 10:25 7 Min. 3 Min.

  • Abstractvortrag

  Processing times of visuospatial standard neurocognition tests depicting deficits linked to the right perisylvian network
• 28.10.2022

  12:15 – 12:25 7 Min. 3 Min.

  • Abstractvortrag

  Dual CAR-T cell approach in ex vivo glioblastoma models: A new approach to overcome antigen escape mechanisms
• 29.10.2022

  11:30 – 11:40 7 Min. 3 Min.

  • Abstractvortrag

  Pseudoprogression in cases of brain metastases and its neurooncological pitfalls under PD-1 inhibitor therapy in the era of personalized medicine